Hung-chih Y. Hsu

Linkou Branch
Taoyuan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 21, 2026

Optimizing third-line and beyond therapies for metastatic colorectal cancer in Taiwan: an evidence-based consensus.

Optimizing third-line and beyond therapies for metastatic colorectal cancer in Taiwan: an evidence-based consensus.

Journal: Therapeutic advances in medical oncology

Published: February 02, 2026

Trifluridine/tipiracil and survival in mismatch repair-deficient metastatic colorectal cancer.

Trifluridine/tipiracil and survival in mismatch repair-deficient metastatic colorectal cancer.

Journal: Therapeutic advances in medical oncology

Published: December 29, 2025

Validation of WHO 2017 Classification and Identification of Prognostic Factors in Patients with Pancreatic Neuroendocrine Neoplasms: A Real-World Experience in Taiwan.

Validation of WHO 2017 Classification and Identification of Prognostic Factors in Patients with Pancreatic Neuroendocrine Neoplasms: A Real-World Experience in Taiwan.

Journal: Journal of Cancer

Published: August 18, 2025

Oral bioavailable ITRI-148 degrades androgen receptor variants and overcomes antiandrogen resistance in advanced prostate cancer.

Oral bioavailable ITRI-148 degrades androgen receptor variants and overcomes antiandrogen resistance in advanced prostate cancer.

Journal: Neoplasia (New York, N.Y.)

Published: July 10, 2025

Efficacy and safety of first-line cetuximab therapy for older patients (aged ≥ 70 years) with RAS wild-type metastatic colorectal cancer: a nationwide real-world study.

Efficacy and safety of first-line cetuximab therapy for older patients (aged ≥ 70 years) with RAS wild-type metastatic colorectal cancer: a nationwide real-world study.

Journal: American journal of cancer research

Published: June 04, 2025

Functional dynamic modulation of colorectal cancer initiation and metastatic capacity by a novel MiR-7974 regulatory axis.

Functional dynamic modulation of colorectal cancer initiation and metastatic capacity by a novel MiR-7974 regulatory axis.

Journal: Biomedical journal

Published: March 27, 2025

Expression of Bacillus in colorectal tissues is associated with improved cetuximab therapy for patients with metastatic colorectal cancer.

Expression of Bacillus in colorectal tissues is associated with improved cetuximab therapy for patients with metastatic colorectal cancer.

Journal: Translational oncology

Published: February 14, 2025

Platelet rich plasma promotes cell migration of adipose-derived stem cells by up-regulation of focal adhesion kinase and paxillin.

Platelet rich plasma promotes cell migration of adipose-derived stem cells by up-regulation of focal adhesion kinase and paxillin.

Journal: Regenerative therapy

Published: November 13, 2024

Outcomes of upfront primary tumor resection in patients with synchronous RAS wild-type metastatic colorectal cancer.

Outcomes of upfront primary tumor resection in patients with synchronous RAS wild-type metastatic colorectal cancer.

Journal: American journal of cancer research

Published: October 07, 2024

PROTACs as Therapeutic Modalities for Drug Discovery in Castration-Resistant Prostate Cancer.

PROTACs as Therapeutic Modalities for Drug Discovery in Castration-Resistant Prostate Cancer.

Journal: Annual review of pharmacology and toxicology

Published: August 08, 2024

Prognostic significance of perioperative circulating CD56bright NK cell and recovery of NK cell activity in patients with colorectal cancer undergoing radical surgery.

Prognostic significance of perioperative circulating CD56bright NK cell and recovery of NK cell activity in patients with colorectal cancer undergoing radical surgery.

Journal: Translational oncology

Published: July 05, 2024

Showing 1-12 of 79

Last Updated: 09/26/2026